Ultragenyx Earlier Enters into Strategic Partnership with Daiichi Sankyo for Gene Therapy Manufacturing Technology; Ultragenyx To Receive $200M Upfront, Including $125M In Cash And $75M Via Equity Investment
Benzinga Newsdesk